[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MD20100029A - Herpesvirus recombinant al crapului de koi (KHV) sau Cyprinid herpesvirus 3 (CyHV-3) si vaccin pentru prevenirea bolii cauzate de KHV/CyHV-3 la Cyprinus carpio carpio sau Cyprinus carpio koi - Google Patents

Herpesvirus recombinant al crapului de koi (KHV) sau Cyprinid herpesvirus 3 (CyHV-3) si vaccin pentru prevenirea bolii cauzate de KHV/CyHV-3 la Cyprinus carpio carpio sau Cyprinus carpio koi

Info

Publication number
MD20100029A
MD20100029A MDA20100029A MD20100029A MD20100029A MD 20100029 A MD20100029 A MD 20100029A MD A20100029 A MDA20100029 A MD A20100029A MD 20100029 A MD20100029 A MD 20100029A MD 20100029 A MD20100029 A MD 20100029A
Authority
MD
Moldova
Prior art keywords
cyhv
khv
herpesvirus
carpio
koi
Prior art date
Application number
MDA20100029A
Other languages
English (en)
Romanian (ro)
Other versions
MD20100029A2 (ro
Inventor
Bérénice COSTES
François LIEFFRIG
Alain Vanderplasschen
Original Assignee
Universite De Liege
Interface Entreprises-Universite
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP07115093A external-priority patent/EP2031065A1/en
Application filed by Universite De Liege, Interface Entreprises-Universite filed Critical Universite De Liege
Publication of MD20100029A2 publication Critical patent/MD20100029A2/ro
Publication of MD20100029A publication Critical patent/MD20100029A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16045—Special targeting system for viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16061—Methods of inactivation or attenuation
    • C12N2710/16062—Methods of inactivation or attenuation by genetic engineering
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/20—Pseudochromosomes, minichrosomosomes
    • C12N2800/204—Pseudochromosomes, minichrosomosomes of bacterial origin, e.g. BAC
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
    • C12N2810/60—Vectors comprising as targeting moiety peptide derived from defined protein from viruses
    • C12N2810/6072—Vectors comprising as targeting moiety peptide derived from defined protein from viruses negative strand RNA viruses
    • C12N2810/6081—Vectors comprising as targeting moiety peptide derived from defined protein from viruses negative strand RNA viruses rhabdoviridae, e.g. VSV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MDA20100029A 2007-08-28 2008-08-26 Herpesvirus recombinant al crapului de koi (KHV) sau Cyprinid herpesvirus 3 (CyHV-3) si vaccin pentru prevenirea bolii cauzate de KHV/CyHV-3 la Cyprinus carpio carpio sau Cyprinus carpio koi MD20100029A (ro)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07115093A EP2031065A1 (en) 2007-08-28 2007-08-28 A recombinant koi herpesvirus (KHV) or Cyprinid herpesvirus 3 (CyHV-3) and a vaccine for the prevention of a disease caused by KHV/CyHV-3 in Cyprinus carpio carpio or Cyprinus carpio koi
EP07120939 2007-11-16
PCT/EP2008/061168 WO2009027412A1 (en) 2007-08-28 2008-08-26 A recombinant koi herpesvirus (khv) or cyprinid herpesvirus 3 (cyhv-3) and a vaccine for the prevention of a disease caused by khv/cyhv-3 in cyprinus carpio carpio or cyprinus carpio koi

Publications (2)

Publication Number Publication Date
MD20100029A2 MD20100029A2 (ro) 2010-08-31
MD20100029A true MD20100029A (ro) 2010-08-31

Family

ID=40020044

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20100029A MD20100029A (ro) 2007-08-28 2008-08-26 Herpesvirus recombinant al crapului de koi (KHV) sau Cyprinid herpesvirus 3 (CyHV-3) si vaccin pentru prevenirea bolii cauzate de KHV/CyHV-3 la Cyprinus carpio carpio sau Cyprinus carpio koi

Country Status (12)

Country Link
US (1) US20110287050A1 (pt)
EP (1) EP2195021B1 (pt)
JP (1) JP2010536394A (pt)
CN (1) CN101820905A (pt)
AT (1) ATE547118T1 (pt)
BR (1) BRPI0816134A2 (pt)
MD (1) MD20100029A (pt)
MX (1) MX2010002122A (pt)
RS (1) RS20100059A (pt)
RU (1) RU2010111725A (pt)
TW (1) TW200924792A (pt)
WO (1) WO2009027412A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2010113988A1 (ja) * 2009-03-31 2012-10-11 国立大学法人三重大学 抗ｇｐｃｒ抗体の製造方法および抗ｇｐｃｒ抗体
EP2487241A1 (en) 2011-02-09 2012-08-15 Westfälische Wilhelms-Universität Münster RNAi agents and compositions useful as carp therapeutics
SG11201403066TA (en) * 2011-12-30 2014-10-30 Université de Liège A recombinant koi herpesvirus (khv) and vaccine for the prevention of a disease caused by khv
CN102973951A (zh) * 2012-11-26 2013-03-20 吉林农业大学 一种锦鲤疱疹病毒orf25核酸疫苗
CN104031143A (zh) * 2013-07-02 2014-09-10 广东省农业科学院动物卫生研究所 一种抗鲤科疱疹病毒3型鸡卵黄抗体及其制备方法和应用
ES2874584T3 (es) * 2015-02-11 2021-11-05 Univ Bologna Alma Mater Studiorum Virus del herpes redirigido con una fusión de glicoproteína H
CN105755014B (zh) * 2016-03-23 2019-03-19 中国科学院水生生物研究所 CaHV-TNFR特异基因及应用
CN106834352B (zh) * 2017-02-27 2020-06-16 苏州大学 基于杆状病毒表达系统制备包裹鲤疱疹病毒ii型抗原的多角体的方法
CN109294974B (zh) * 2018-10-22 2022-09-13 浙江省淡水水产研究所 一种异育银鲫脊髓组织细胞系及其构建方法与其应用
CN112316113B (zh) * 2018-11-05 2023-06-27 共鳞实业(深圳)有限公司 用于预防或治疗鱼类感染CyHV-2的试剂及应用
CN110423714B (zh) * 2019-08-19 2020-11-06 中国水产科学研究院长江水产研究所 一种乳酸菌复合菌剂及其在抗鲤疱疹病毒ii型中的应用
CN113068640A (zh) * 2021-03-19 2021-07-06 北京市水产科学研究所（国家淡水渔业工程技术研究中心） 一种红色皮肤高覆盖率锦鲤品系的选育方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE115862T1 (de) 1989-02-04 1995-01-15 Akzo Nobel Nv Tocole als impfstoffadjuvans.
JPH09267A (ja) * 1995-06-23 1997-01-07 Kyoritsu Shoji Kk チミジンキナーゼ遺伝子に変異を有する組換えネコヘルペスウイルス１型及びそれを含むワクチン
CA2352563C (en) 1998-12-21 2010-08-17 Akzo Nobel N.V. Method to produce inactivated w/o emulsion adjuvanted vaccines
IL153775A0 (en) 2003-01-01 2003-07-31 Yissum Res Dev Co Immunizing fish against viral infection

Also Published As

Publication number Publication date
RU2010111725A (ru) 2011-10-10
TW200924792A (en) 2009-06-16
WO2009027412A1 (en) 2009-03-05
ATE547118T1 (de) 2012-03-15
MD20100029A2 (ro) 2010-08-31
EP2195021A1 (en) 2010-06-16
EP2195021B1 (en) 2012-02-29
US20110287050A1 (en) 2011-11-24
RS20100059A (en) 2011-06-30
MX2010002122A (es) 2010-07-06
JP2010536394A (ja) 2010-12-02
BRPI0816134A2 (pt) 2015-07-28
CN101820905A (zh) 2010-09-01

Similar Documents

Publication Publication Date Title
MD20100029A (ro) Herpesvirus recombinant al crapului de koi (KHV) sau Cyprinid herpesvirus 3 (CyHV-3) si vaccin pentru prevenirea bolii cauzate de KHV/CyHV-3 la Cyprinus carpio carpio sau Cyprinus carpio koi
HK1120730A1 (en) Nipah virus vaccines nipah
EA201070794A1 (ru) Рекомбинантные антигены rsv
WO2008054540A3 (en) Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions
EA201170493A1 (ru) Микроорганизмы и вакцины, зависимые от репликации неприродных аминокислот
EA201270063A1 (ru) Рекомбинантные антигены pcb
WO2009060281A3 (en) Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties
HK1124868A1 (en) Truncated human papillomavirus type 16 l1 proteins
MX2010012999A (es) Vacuna de vesícula de membrana externa nativa multivalente del meningococo, método para su fabricación y uso.
PH12014501388A1 (en) A recombinant koi herpesvirus (khv) and vaccine for the prevention of a disease caused by khv
WO2007150008A3 (en) Polypeptides from african swine virus as vaccines for preventive and therapeutic use
NZ600544A (en) Compositions and methods for the treatment of angiogenesis-related eye diseases
WO2008054535A3 (en) Novel influenza m2 vaccines
WO2010014567A3 (en) Variant hcmv pp65, ie1, and ie2 polynucleotides and uses thereof
EP2552490A4 (en) INFLUENZA MATRIX 2 PROTEIN ECKTOMOMAS, EXPRESSION SYSTEM THEREFOR AND USES THEREOF
UA114286C2 (uk) Спосіб лікування staphylococcus aureus
SI1949913T1 (sl) Imunsko stimulacijska kombinacija za zaĺ äśito in zdravljenje hepatitisa c
WO2008133208A1 (ja) ペプチド免疫応答増強方法
MX2011003535A (es) Composiciones de virus de herpes bovino-1, vacunas, y metodos.
EP1471936A4 (en) HIV VACCINE AND METHOD OF USE
TW200637573A (en) Peptide for delivery of mucosal vaccines
CL2013002631A1 (es) Virus de la necrosis pancreatica infecciosa (ipnv) avirulento porque comprende proteina vp2 madura.
WO2008153772A3 (en) Chlamydia vaccine comprising htra polypeptides
AR040601A1 (es) Mutantes ehv negativos de gm sin elementos heterologos
EA201591095A1 (ru) Белок slurp-1 для применения в лечении глазных болезней

Legal Events

Date Code Title Description
FA9A Abandonment or withdrawal of application (patent for invention)